Published in DNA on January 01, 1982
A mammalian high mobility group protein recognizes any stretch of six A.T base pairs in duplex DNA. Proc Natl Acad Sci U S A (1986) 3.49
Genetic analysis of the interaction of the insertion sequence IS903 transposase with its terminal inverted repeats. Proc Natl Acad Sci U S A (1987) 2.04
Definition of three resolvase binding sites at the res loci of Tn21 and Tn1721. EMBO J (1985) 1.44
The Fidelity Index provides a systematic quantitation of star activity of DNA restriction endonucleases. Nucleic Acids Res (2008) 1.34
Construction of bacteriophage T7 late promoters with point mutations and characterization by in vitro transcription properties. Nucleic Acids Res (1987) 1.31
Proton exchange and base-pair opening kinetics in 5'-d(CGCGAATTCGCG)-3' and related dodecamers. Nucleic Acids Res (1990) 1.22
Type II restriction endonucleases--a historical perspective and more. Nucleic Acids Res (2014) 1.22
Mutants of the EcoRI endonuclease with promiscuous substrate specificity implicate residues involved in substrate recognition. EMBO J (1990) 1.15
Changes in solvation during DNA binding and cleavage are critical to altered specificity of the EcoRI endonuclease. Proc Natl Acad Sci U S A (1998) 1.13
Site directed mutagenesis experiments suggest that Glu 111, Glu 144 and Arg 145 are essential for endonucleolytic activity of EcoRI. Nucleic Acids Res (1986) 1.10
Differences between EcoRI nonspecific and "star" sequence complexes revealed by osmotic stress. Biophys J (2004) 1.01
In vivo specificity of EcoRI DNA methyltransferase. Nucleic Acids Res (1992) 0.81
Sequence-specific recognition of double helical nucleic acids by proteins. Proc Natl Acad Sci U S A (1976) 13.30
Specificity of substrate recognition by the EcoRI restriction endonuclease. Proc Natl Acad Sci U S A (1975) 11.07
Structure of the DNA-Eco RI endonuclease recognition complex at 3 A resolution. Science (1986) 4.89
Double helix at atomic resolution. Nature (1973) 2.84
Refinement of Eco RI endonuclease crystal structure: a revised protein chain tracing. Science (1990) 2.74
Sequence analysis of the DNA encoding the Eco RI endonuclease and methylase. J Biol Chem (1981) 2.62
Kinked DNA in crystalline complex with EcoRI endonuclease. Nature (1984) 2.46
A crystalline fragment of the double helix: the structure of the dinucleoside phosphate guanylyl-3',5'-cytidine. Proc Natl Acad Sci U S A (1973) 2.39
RNA double-helical fragments at atomic resolution. I. The crystal and molecular structure of sodium adenylyl-3',5'-uridine hexahydrate. J Mol Biol (1976) 2.25
The bone induction principle. Clin Orthop Relat Res (1968) 2.23
Dietetic guidelines on food and nutrition in the secondary prevention of cardiovascular disease - evidence from systematic reviews of randomized controlled trials (second update, January 2006). J Hum Nutr Diet (2006) 2.09
RNA double-helical fragments at atomic resolution. II. The crystal structure of sodium guanylyl-3',5'-cytidine nonahydrate. J Mol Biol (1976) 2.07
Oral and genital tardive pain syndromes. Neurology (1994) 2.07
Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease. Dev Genet (1999) 1.80
Radial artery pressure monitoring underestimates central arterial pressure during vasopressor therapy in critically ill surgical patients. Crit Care Med (1998) 1.72
Knowledge, attitudes, and behaviors of Alabama's primary care physicians regarding cancer genetics. Acad Med (2000) 1.71
Simultaneous aortic, jugular bulb, and right atrial pressures during cardiopulmonary resuscitation in humans. Insights into mechanisms. Circulation (1989) 1.69
Delayed-onset cerebellar syndrome. Arch Neurol (1996) 1.65
Outcome of selective ramisectomy for botulinum toxin resistant torticollis. J Neurol Neurosurg Psychiatry (1998) 1.52
Current concepts on the clinical features, aetiology and management of idiopathic cervical dystonia. Brain (1998) 1.50
Kinetic studies of inducer binding to lac repressor.operator complex. J Biol Chem (1980) 1.35
Coordinate ion pair formation between EcoRI endonuclease and DNA. J Biol Chem (1983) 1.30
Molecular dynamics simulation study of DNA dodecamer d(CGCGAATTCGCG) in solution: conformation and hydration. J Mol Biol (1997) 1.21
Lac repressor purification without inactivation of DNA binding activity. Nucleic Acids Res (1977) 1.20
Comparison of the nucleotide and amino acid sequences of the RsrI and EcoRI restriction endonucleases. Gene (1989) 1.19
Equilibrium binding of inducer to lac repressor.operator DNA complex. J Biol Chem (1980) 1.17
RNA double helices generated from crystal structures of double helical dinucleoside phosphates. Biochem Biophys Res Commun (1976) 1.16
Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms. Heparan sulfate glycosaminoglycan requirement for Met binding and signaling. J Biol Chem (1997) 1.09
Comparison of media with and without 'Panmede' for the isolation of Streptobacillus moniliformis from blood cultures and observations on the inhibitory effect of sodium polyanethol sulphonate. J Med Microbiol (1985) 1.06
The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography. J Neurol Neurosurg Psychiatry (1991) 1.05
Subthalamic nucleus stimulation in advanced Parkinson's disease: blinded assessments at one year follow up. J Neurol Neurosurg Psychiatry (2004) 1.05
The metabolic anatomy of Parkinson's disease: complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies. Mov Disord (1990) 1.03
Blinded positron emission tomography study of dopamine cell implantation for Parkinson's disease. Ann Neurol (2001) 0.96
[Botulinum toxin as a powerful new tool in the treatment of focal dystonia]. Harefuah (1991) 0.96
Use of intrathecal baclofen in the treatment of patients with dystonia. Arch Neurol (1996) 0.91
Carcinoid tumors of the colon. A study of 72 patients. Am J Surg (1985) 0.91
Sugar transport by the bacterial phosphotransferase system. Evidence that crr is the structural gene for the Salmonella typhimurium glucose-specific phosphocarrier protein IIIGlc. J Biol Chem (1982) 0.91
Oral and genital pain syndromes in Parkinson's disease. Mov Disord (1996) 0.90
Dynamic contributions to the DNA binding entropy of the EcoRI and EcoRV restriction endonucleases. J Mol Biol (1996) 0.90
Clustering of null mutations in the EcoRI endonuclease. Proteins (1987) 0.90
Preliminary x-ray diffraction analysis of crystalline EcoRI endonuclease. J Mol Biol (1978) 0.89
Hepatocyte growth factor (HGF/SF) in Alzheimer's disease. Brain Res (1998) 0.89
Educational programs offered by colleges of pharmacy and drug information centers within the United States. Am J Pharm Educ (1984) 0.89
Statistical methods for the objective design of screening procedures for macromolecular crystallization. Acta Crystallogr D Biol Crystallogr (2000) 0.88
Dietetic guidelines: diet in secondary prevention of cardiovascular disease (first update, June 2003). J Hum Nutr Diet (2004) 0.87
The neurovascular outcome of scapulothoracic dissociation. J Vasc Surg (1993) 0.87
Use of research-based practices by oncology staff nurses. Oncol Nurs Forum (1996) 0.87
Preparing children for medical examinations: the importance of previous medical experience. Health Psychol (1986) 0.86
Factors affecting survival after ruptured abdominal aortic aneurysm. J Vasc Surg (1985) 0.86
Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patients. Arch Neurol (1996) 0.86
Preliminary characterization of EcoRI-DNA co-crystals: incomplete factorial design of oligonucleotide sequences. Acta Crystallogr D Biol Crystallogr (1995) 0.85
Risperidone in Parkinson's disease. Lancet (1994) 0.85
Environmentally induced conformational changes in B-type DNA: comparison of the conformation of the oligonucleotide d(TCGCGAATTCGCG) in solution and in its crystalline complex with the restriction nuclease EcoRI. Biochemistry (1989) 0.85
Positron emission tomographic findings in Filipino X-linked dystonia-parkinsonism. Ann Neurol (1993) 0.84
Molecular dynamics simulations suggest that the Eco RI kink is an example of molecular strain. J Biomol Struct Dyn (1994) 0.84
Conditioning of appetitive and consummatory sexual behavior in male Japanese quail. J Exp Anal Behav (1988) 0.83
The structure and function of the Eco RI restriction endonuclease. Gene Amplif Anal (1981) 0.83
Determinants of EcoRI endonuclease sequence discrimination. Proc Natl Acad Sci U S A (1989) 0.82
Purification and characterization of the restriction endonuclease RsrI, an isoschizomer of EcoRI. Gene (1988) 0.82
Salivary cotinine, frequency of cigarette smoking, and body mass index: findings at baseline in the Lung Health Study. Am J Epidemiol (1994) 0.82
Paroxysmal kinesigenic dystonic choreoathetosis associated with a thalamic infarct. Mov Disord (1990) 0.82
Cancer of the head of the pancreas: an institutional review with emphasis on surgical therapy. J Surg Oncol (1985) 0.81
Complexes between chaperonin GroEL and the capsid protein of bacteriophage HK97. Biochemistry (1995) 0.81
Pharmacist-manned drug information centers in the United States. Am J Hosp Pharm (1977) 0.80
Cognition following bilateral implants of embryonic dopamine neurons in PD: a double blind study. Neurology (2003) 0.80
Pharmacokinetics of recombinant human superoxide dismutase in healthy volunteers. Clin Pharmacol Ther (1991) 0.80
Elevation of brain manganese in calcium-deficient rats. Neurotoxicology (1991) 0.79
Coping with problems related to cancer and cancer treatment. CA Cancer J Clin (1987) 0.78
Large-scale purification of two forms of active lac operator from plasmids. Biochim Biophys Acta (1980) 0.78
Calcium deficiency enhances cadmium accumulation in the central nervous system. Brain Res (1991) 0.78
Probing the role of glutamic acid 144 in the EcoRI endonuclease using aspartic acid and glutamine replacements. J Biol Chem (1990) 0.78
The renin angiotensin aldosterone system and frusemide response in congestive heart failure. Br J Clin Pharmacol (1995) 0.78
Two-fold symmetry of crystalline DNA-EcoRI endonuclease recognition complexes. J Biomol Struct Dyn (1984) 0.77
Differences in the inhibition of translation by cisplatin, transplatin, and certain related compounds. Biochem Pharmacol (1996) 0.77
Arm elevation in Huntington's disease: dystonia or levitation? Mov Disord (1999) 0.77
Spin-labeled nucleotide mobility in the boundary of the EcoRI endonuclease binding site. J Biomol Struct Dyn (1996) 0.77
An in vivo study of phosphorus and glucose metabolism in Alzheimer's disease using magnetic resonance spectroscopy and PET. Arch Gen Psychiatry (1993) 0.77
Contextual conditioning and the control of copulatory behavior by species-specific sign stimuli in male Japanese quail. J Exp Psychol Anim Behav Process (1989) 0.76
Potency of frozen/thawed botulinum toxin type A in the treatment of torsion dystonia. Otolaryngol Head Neck Surg (1993) 0.76
Community supports for individuals with challenging behavior after brain injury: an analysis of the New York state behavioral resource project. J Head Trauma Rehabil (2001) 0.76
Comment: natural products and the athlete: facts and folklore. Ann Pharmacother (1993) 0.75
Drug information centers: future trends. Am J Hosp Pharm (1983) 0.75
Induction of rules for biological macromolecule crystallization. Proc Int Conf Intell Syst Mol Biol (1994) 0.75
Ileal tumor causing carcinoid syndrome without hepatic metastases. Arch Surg (1984) 0.75
Clinical experience with sotalol in the treatment of cardiac arrhythmias. Clin Ther (1994) 0.75
A drug information service in a community hospital. Am J Hosp Pharm (1971) 0.75
What to look out for with guanethidine and reserpine. RN (1984) 0.75
What to watch for with thiazides. RN (For Managers) (1983) 0.75
Clostridium difficile colitis in surgical patients. Am J Surg (1984) 0.75
Comparative content evaluation of the de Haen and Drugdex drug information systems. Am J Hosp Pharm (1983) 0.75
I.V. additives move to the pharmacy. Hospitals (1971) 0.75
What to watch out for with nonthiazides. RN (For Managers) (1983) 0.75
What to watch out for with emergency antihypertensives. RN (1983) 0.75
What to watch out for with alpha-adrenergic blockers. RN (1983) 0.75
Elderly ambulatory care patients' knowledge about drugs. Hosp Pharm (1984) 0.75
Combined carotid endarterectomy and coronary artery bypass in a community hospital. Cardiovasc Surg (1993) 0.75